Preoperative Herceptin and Navelbine for Breast Cancer

Clinical trial NCT00148681 · COMPLETED

Trial details

NCT number: NCT00148681
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Stage II Breast Cancer Stage III Breast Cancer

Start date: 2001-05-01
Primary completion: 2003-05-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.